TipRanks
Yuyu Pharma, Inc. (KR:000220)
:000220
South Korea Market
000220
Yuyu Pharma, Inc.
RESEARCH TOOLSreports

Yuyu Pharma, Inc. (000220) Ratios

― Followers

Yuyu Pharma, Inc. Ratios

KR:000220's free cash flow for Q2 2026 was ₩0.39. For the 2026 fiscal year, KR:000220's free cash flow was decreased by ₩ and operating cash flow was ₩0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.89 1.64 1.58 2.03 1.50
Quick Ratio
 1.00 0.93 0.98 1.15 0.88
Cash Ratio
 0.43 0.49 0.65 0.61 0.40
Solvency Ratio
 0.29 0.21 0.20 -0.02 <0.01
Operating Cash Flow Ratio
 0.43 0.27 0.39 <0.01 -0.10
Short-Term Operating Cash Flow Coverage
 0.92 0.59 0.76 0.02 -0.17
Net Current Asset Value
₩ 29.72B₩ 29.88B₩ 29.32B₩ 23.74B₩ 24.53B
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.16 0.20 0.20
Debt-to-Equity Ratio
 0.21 0.22 0.27 0.35 0.34
Debt-to-Capital Ratio
 0.17 0.18 0.21 0.26 0.25
Long-Term Debt-to-Capital Ratio
 0.04 0.00 <0.01 0.11 0.01
Financial Leverage Ratio
 1.54 1.60 1.66 1.77 1.67
Debt Service Coverage Ratio
 0.32 0.50 0.53 0.17 0.07
Interest Coverage Ratio
 2.60 1.98 3.63 0.14 0.27
Debt to Market Cap
 0.46 0.36 0.45 0.39 0.37
Interest Debt Per Share
 2.10K 2.02K 2.28K 2.26K 2.52K
Net Debt to EBITDA
 0.74 -0.07 -0.43 1.81 3.95
Profitability Margins
Gross Profit Margin
38.17%38.29%38.83%35.37%38.39%
EBIT Margin
2.73%7.82%9.92%-0.55%-0.89%
EBITDA Margin
6.65%11.80%14.17%3.54%2.45%
Operating Profit Margin
9.12%7.82%8.79%0.27%0.50%
Pretax Profit Margin
9.09%6.73%7.50%-3.97%-2.74%
Net Profit Margin
8.66%5.79%6.55%-5.23%-3.19%
Continuous Operations Profit Margin
8.61%6.47%7.73%-4.04%-3.19%
Net Income Per EBT
95.26%85.99%87.34%131.95%116.14%
EBT Per EBIT
99.73%86.06%85.36%-1492.89%-550.83%
Return on Assets (ROA)
6.01%3.93%4.20%-3.62%-2.27%
Return on Equity (ROE)
9.56%6.31%6.96%-6.40%-3.79%
Return on Capital Employed (ROCE)
8.25%7.43%8.17%0.25%0.53%
Return on Invested Capital (ROIC)
6.84%6.02%6.63%0.21%0.41%
Return on Tangible Assets
6.09%3.99%4.26%-3.70%-2.31%
Earnings Yield
21.01%10.89%11.96%-7.23%-4.26%
Efficiency Ratios
Receivables Turnover
 7.94 7.09 6.75 6.60 6.33
Payables Turnover
 9.80 4.46 8.60 8.10 5.40
Inventory Turnover
 2.07 2.06 2.11 2.01 2.15
Fixed Asset Turnover
 1.44 1.51 1.48 1.69 1.71
Asset Turnover
 0.69 0.68 0.64 0.69 0.71
Working Capital Turnover Ratio
 3.55 3.74 2.99 3.28 2.75
Cash Conversion Cycle
 185.25 146.92 184.74 191.98 160.00
Days of Sales Outstanding
 45.95 51.51 54.09 55.33 57.66
Days of Inventory Outstanding
 176.56 177.25 173.12 181.72 169.91
Days of Payables Outstanding
 37.25 81.84 42.46 45.08 67.57
Operating Cycle
 222.50 228.76 227.21 237.06 227.57
Cash Flow Ratios
Operating Cash Flow Per Share
 1.33K 968.39 1.54K 22.68 -375.68
Free Cash Flow Per Share
 367.19 470.96 1.09K -252.51 -711.47
CapEx Per Share
 960.43 497.43 451.31 275.19 335.80
Free Cash Flow to Operating Cash Flow
 0.28 0.49 0.71 -11.13 1.89
Dividend Paid and CapEx Coverage Ratio
 1.21 1.58 2.80 0.06 -0.82
Capital Expenditure Coverage Ratio
 1.38 1.95 3.42 0.08 -1.12
Operating Cash Flow Coverage Ratio
 0.75 0.58 0.74 0.01 -0.16
Operating Cash Flow to Sales Ratio
 0.14 0.11 0.19 <0.01 -0.04
Free Cash Flow Yield
9.71%10.43%24.20%-4.72%-11.37%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 5.06 9.18 9.62 -13.82 -23.45
Price-to-Sales (P/S) Ratio
 0.41 0.53 0.55 0.72 0.75
Price-to-Book (P/B) Ratio
 0.44 0.58 0.58 0.88 0.89
Price-to-Free Cash Flow (P/FCF) Ratio
 10.29 9.59 4.13 -21.19 -8.80
Price-to-Operating Cash Flow Ratio
 2.85 4.66 2.92 235.88 -16.66
Price-to-Earnings Growth (PEG) Ratio
 0.04 1.80 -0.04 -0.31 -0.06
Price-to-Fair Value
 0.44 0.58 0.58 0.88 0.89
Enterprise Value Multiple
 6.94 4.44 3.43 22.24 34.45
Enterprise Value
 66.59B 73.74B 64.72B 108.07B 117.23B
EV to EBITDA
 6.94 4.44 3.43 22.24 34.45
EV to Sales
 0.46 0.52 0.49 0.79 0.84
EV to Free Cash Flow
 11.52 9.44 3.67 -23.07 -9.94
EV to Operating Cash Flow
 3.19 4.59 2.59 256.79 -18.82
Tangible Book Value Per Share
 9.12K 8.28K 8.15K 6.26K 7.22K
Shareholders’ Equity Per Share
 8.56K 7.79K 7.74K 6.05K 7.05K
Tax and Other Ratios
Effective Tax Rate
 0.05 0.04 -0.03 -0.02 -0.16
Revenue Per Share
 9.17K 8.49K 8.23K 7.39K 8.38K
Net Income Per Share
 794.02 491.47 538.86 -387.00 -266.90
Tax Burden
 0.95 0.86 0.87 1.32 1.16
Interest Burden
 3.33 0.86 0.76 7.27 3.10
Research & Development to Revenue
 0.02 0.03 0.02 0.05 0.06
SG&A to Revenue
 0.17 0.14 0.13 0.12 0.14
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.67 1.76 2.42 -0.06 1.41
Currency in KRW